Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (181-190 of 358) with videos related to

Pageof 36
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|November 1, 2011
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)Antonio D'Avolio, Marco Simiele, Silvia De Francia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 15, 2013
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype DLucio Boglione, Antonio D'Avolio, Giuseppe Cariti, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 1, 2016
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasmaAlessandra Ariaudo, Fabio Favata, Amedeo De Nicolò, et al.
Clinics and Research in Hepatology and Gastroenterology|November 1, 2018
Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experienceAlfredo Alberti, Gioacchino Angarano, Massimo Colombo, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2020
Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal DisordersAndrea Calcagno, Ivano Dal Conte, Dario Cattaneo, et al.
Clinical and Experimental Pharmacology & Physiology|July 27, 2017
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in childrenSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
The New Microbiologica|April 29, 2008
SPIR01 and SPIR02: a two-year 1-day point prevalence multicenter study of infections in intensive care units in Piedmont, ItalyFrancesco G De Rosa, Silvia Garazzino, Sabrina Audagnotto, et al.
Analytical and Bioanalytical Chemistry|November 10, 2009
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasmaLorena Baietto, Antonio D'Avolio, Francesco Giuseppe De Rosa, et al.
Pharmacogenomics|June 20, 2018
Pharmacogenetic of voriconazole antifungal agent in pediatric patientsSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
Journal of Clinical Pharmacology|June 7, 2018
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid ConcentrationsSarah Allegra, Chiara Simona Cardellino, Giovanna Fatiguso, et al.
Pageof 36

Showing results (181-190 of 358) with videos related to

Sort By:
Pageof 36
Journal of Pharmaceutical and Biomedical Analysis|November 1, 2011
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)Antonio D'Avolio, Marco Simiele, Silvia De Francia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 15, 2013
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype DLucio Boglione, Antonio D'Avolio, Giuseppe Cariti, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 1, 2016
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasmaAlessandra Ariaudo, Fabio Favata, Amedeo De Nicolò, et al.
Clinics and Research in Hepatology and Gastroenterology|November 1, 2018
Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experienceAlfredo Alberti, Gioacchino Angarano, Massimo Colombo, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2020
Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal DisordersAndrea Calcagno, Ivano Dal Conte, Dario Cattaneo, et al.
Clinical and Experimental Pharmacology & Physiology|July 27, 2017
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in childrenSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
The New Microbiologica|April 29, 2008
SPIR01 and SPIR02: a two-year 1-day point prevalence multicenter study of infections in intensive care units in Piedmont, ItalyFrancesco G De Rosa, Silvia Garazzino, Sabrina Audagnotto, et al.
Analytical and Bioanalytical Chemistry|November 10, 2009
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasmaLorena Baietto, Antonio D'Avolio, Francesco Giuseppe De Rosa, et al.
Pharmacogenomics|June 20, 2018
Pharmacogenetic of voriconazole antifungal agent in pediatric patientsSarah Allegra, Giovanna Fatiguso, Silvia De Francia, et al.
Journal of Clinical Pharmacology|June 7, 2018
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid ConcentrationsSarah Allegra, Chiara Simona Cardellino, Giovanna Fatiguso, et al.
Pageof 36